Wealth Enhancement Advisory Services LLC Boosts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Wealth Enhancement Advisory Services LLC raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 43.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,038 shares of the medical instruments supplier’s stock after buying an additional 3,671 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in DENTSPLY SIRONA were worth $326,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. First Eagle Investment Management LLC boosted its position in DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after buying an additional 3,283,965 shares during the period. Nuance Investments LLC boosted its position in DENTSPLY SIRONA by 3.8% in the 2nd quarter. Nuance Investments LLC now owns 10,879,916 shares of the medical instruments supplier’s stock valued at $271,019,000 after buying an additional 402,329 shares during the period. Cooke & Bieler LP boosted its position in DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after buying an additional 1,046,105 shares during the period. Price T Rowe Associates Inc. MD boosted its position in DENTSPLY SIRONA by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,266,781 shares of the medical instruments supplier’s stock valued at $207,995,000 after buying an additional 343,915 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after buying an additional 1,308,411 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $17.86 on Monday. The company’s fifty day moving average price is $24.68 and its 200 day moving average price is $25.83. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $37.60. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.87. The firm has a market capitalization of $3.62 billion, a P/E ratio of -8.63, a P/E/G ratio of 0.97 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period last year, the business earned $0.49 EPS. DENTSPLY SIRONA’s revenue for the quarter was up .4% compared to the same quarter last year. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on XRAY. Evercore ISI decreased their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday. Stifel Nicolaus decreased their price objective on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. Needham & Company LLC decreased their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Finally, Barrington Research decreased their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.